Kelsey Moody
Vorstandsvorsitzender bei Antoxerene, Inc.
Profil
Kelsey Moody is the founder and Chief Executive Officer of Auctus Biologicos, Inc., which was founded in 2018.
He is also currently the Chief Executive Officer of Antoxerene, Inc., Ichor Therapeutics, Inc., and President & Director of Lysoclear, Inc. Additionally, he serves as a Scientific Advisor at Methuselah Capital Management LLC.
Aktive Positionen von Kelsey Moody
Unternehmen | Position | Beginn |
---|---|---|
Antoxerene, Inc.
Antoxerene, Inc. BiotechnologyHealth Technology Antoxerene, Inc. operates as a pharmaceutical company. It develops small molecule senolytic drugs for pathways of aging. The company was incorporated in 2016 and is headquartered in Lafayette, NY. | Vorstandsvorsitzender | - |
Lysoclear, Inc.
Lysoclear, Inc. Pharmaceuticals: MajorHealth Technology Lysoclear, Inc. owns and operates pharmaceuticals. It engages in treatment of age-related macular and Stargardt’s macular degeneration. The company is headquartered in Lafayette, NY. | Präsident | - |
Auctus Biologicos, Inc.
Auctus Biologicos, Inc. BiotechnologyHealth Technology Auctus Biologicos, Inc. is a biotechnology company based in Lafayette, NY. The company was founded in 2018 by Aaron Wolfe and Kelsey Moody, with Kelsey Moody serving as the CEO since then. | Vorstandsvorsitzender | 01.01.2018 |
Ichor Therapeutics, Inc.
Ichor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ichor Therapeutics, Inc. is a full-service contract research organization and American longevity biotechnology company. Ichor's CRO services help biotechnology and pharmaceutical companies solve their most difficult challenges, from preclinical studies to late-stage clinical trials and FDA approval, using a personalized approach that puts relationships and science first. As a longevity biotechnology company, Ichor aims to help people live longer, healthier lives by developing therapies with the potential to treat age-related diseases. The private company is pioneering the longevity and anti-aging biotechnology industry while empowering CRO clients to rapidly advance their research and development programs. The company was founded in 2013 in upstate New York and has subsidiaries in the United States. The CEO is Kelsey Moody. | Vorstandsvorsitzender | 01.05.2013 |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Berater | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Antoxerene, Inc.
Antoxerene, Inc. BiotechnologyHealth Technology Antoxerene, Inc. operates as a pharmaceutical company. It develops small molecule senolytic drugs for pathways of aging. The company was incorporated in 2016 and is headquartered in Lafayette, NY. | Health Technology |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Finance |
Ichor Therapeutics, Inc.
Ichor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ichor Therapeutics, Inc. is a full-service contract research organization and American longevity biotechnology company. Ichor's CRO services help biotechnology and pharmaceutical companies solve their most difficult challenges, from preclinical studies to late-stage clinical trials and FDA approval, using a personalized approach that puts relationships and science first. As a longevity biotechnology company, Ichor aims to help people live longer, healthier lives by developing therapies with the potential to treat age-related diseases. The private company is pioneering the longevity and anti-aging biotechnology industry while empowering CRO clients to rapidly advance their research and development programs. The company was founded in 2013 in upstate New York and has subsidiaries in the United States. The CEO is Kelsey Moody. | Commercial Services |
Lysoclear, Inc.
Lysoclear, Inc. Pharmaceuticals: MajorHealth Technology Lysoclear, Inc. owns and operates pharmaceuticals. It engages in treatment of age-related macular and Stargardt’s macular degeneration. The company is headquartered in Lafayette, NY. | Health Technology |
Auctus Biologicos, Inc.
Auctus Biologicos, Inc. BiotechnologyHealth Technology Auctus Biologicos, Inc. is a biotechnology company based in Lafayette, NY. The company was founded in 2018 by Aaron Wolfe and Kelsey Moody, with Kelsey Moody serving as the CEO since then. | Health Technology |